Erste Asset Management Reduces Johnson & Johnson Stake

Institutional investor sells over 14,000 shares of healthcare giant

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Erste Asset Management GmbH, an institutional investor, lowered its position in Johnson & Johnson (NYSE: JNJ) by 4.1% during the 3rd quarter, according to a recent SEC filing. The firm now owns 333,688 shares of the company's stock, valued at $60.9 million.

Why it matters

Johnson & Johnson is a major pharmaceutical and healthcare company, so changes in institutional ownership of its stock can provide insights into broader market and industry trends. Erste Asset Management's decision to reduce its JNJ holdings may signal a shift in investor sentiment or portfolio strategy.

The details

According to the SEC filing, Erste Asset Management sold 14,363 shares of Johnson & Johnson stock during the 3rd quarter. This reduced the firm's total position to 333,688 shares, worth approximately $60.9 million. The filing did not provide specific reasons for the portfolio adjustment.

  • Erste Asset Management reduced its Johnson & Johnson stake during the 3rd quarter of 2026.

The players

Erste Asset Management GmbH

An institutional investor that manages assets for clients.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

While the reasons behind Erste Asset Management's decision to reduce its Johnson & Johnson holdings are not entirely clear, the move reflects broader shifts in institutional investment strategies and market sentiment around the healthcare sector.